BlackRock Inc. - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 73 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$10,471,444
-13.6%
6,088,049
-2.0%
0.00%
Q2 2023$12,116,193
+125.5%
6,213,432
+221.5%
0.00%
Q1 2023$5,372,781
-20.3%
1,932,655
-1.1%
0.00%
Q4 2022$6,743,142
+36.3%
1,954,534
+1.5%
0.00%
Q3 2022$4,949,000
+6.9%
1,925,952
+0.6%
0.00%
Q2 2022$4,631,000
-71.1%
1,913,871
-50.8%
0.00%
Q1 2022$16,041,000
-67.1%
3,893,393
+2.7%
0.00%
-100.0%
Q4 2021$48,757,000
+42.2%
3,791,433
+19.4%
0.00%0.0%
Q3 2021$34,282,000
+31.5%
3,174,318
+11.2%
0.00%0.0%
Q2 2021$26,065,000
+15.3%
2,854,868
+19.1%
0.00%0.0%
Q1 2021$22,600,000
+191.8%
2,396,776
+21.9%
0.00%
Q4 2020$7,745,000
+19.8%
1,965,506
-19.4%
0.00%
Q3 2020$6,463,000
-60.3%
2,438,958
-0.6%
0.00%
-100.0%
Q2 2020$16,299,000
+28.5%
2,454,874
+12.6%
0.00%0.0%
Q1 2020$12,686,000
-29.4%
2,179,680
+8.8%
0.00%0.0%
Q4 2019$17,964,000
+30.7%
2,002,681
+25.8%
0.00%0.0%
Q3 2019$13,743,000
-19.6%
1,591,527
+3.7%
0.00%0.0%
Q2 2019$17,096,000
+204.3%
1,534,625
+263.2%
0.00%
Q1 2019$5,619,000
-9.1%
422,510
+5.6%
0.00%
Q4 2018$6,182,000400,1040.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,102,929$18,059,047,0004.95%
Svennilson Peter 3,102,934$18,059,0002.29%
Casdin Capital, LLC 2,270,000$13,211,0001.40%
FRAZIER MANAGEMENT LLC 2,061,758$11,999,0001.36%
Redmile Group, LLC 3,068,194$17,857,0000.50%
Alphabet Inc. 929,022$5,407,0000.36%
Bleichroeder LP 169,039$984,0000.26%
Leap Investments LP 14,400$84,0000.12%
DAFNA Capital Management LLC 50,000$291,0000.12%
Blackstone Inc. 2,567,445$14,943,0000.11%
View complete list of GRITSTONE ONCOLOGY INC shareholders